9903 results for "cancer rna-seq"

in 54.72 milliseconds.

• Tumour sample for patient SA420

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA420

  Dataset EGAD00001009519

• Tumour sample for patient SA409

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA409

  Dataset EGAD00001009518

• Tumour sample for patient SA533

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA533

  Dataset EGAD00001009517

• Tumour sample for patient SA234

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA234

  Dataset EGAD00001009525

• Tumour sample for patient SA278

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA278

  Dataset EGAD00001009526

• Tumour sample for patient SA101

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA101

  Dataset EGAD00001009527

• Tumour sample for patient SA212

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA212

  Dataset EGAD00001009528

• Tumour sample for patient SA214

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA214

  Dataset EGAD00001009529

• Tumour sample for patient SA224

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA224

  Dataset EGAD00001009530

• Tumour sample for patient SA225

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA225

  Dataset EGAD00001009531

• Tumour sample for patient SA226

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA226

  Dataset EGAD00001009532

• Tumour sample for patient SA228

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA228

  Dataset EGAD00001009533

• Tumour sample for patient SA229

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA229

  Dataset EGAD00001009534

• Tumour sample for patient SA231

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA231

  Dataset EGAD00001009535

• Tumour sample for patient SA233

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA233

  Dataset EGAD00001009536

• Tumour sample for patient SA237

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA237

  Dataset EGAD00001009537

• Tumour sample for patient SA271

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA271

  Dataset EGAD00001009538

• Tumour sample for patient SA277

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA277

  Dataset EGAD00001009539

• Tumour sample for patient SA284

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA284

  Dataset EGAD00001009540

• Tumour sample for patient SA399

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA399

  Dataset EGAD00001009541

• Tumour sample for patient SA294

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA294

  Dataset EGAD00001009542

• Tumour sample for patient SA285

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA285

  Dataset EGAD00001009543

• Normal sample for patient SA101

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA101

  Dataset EGAD00001009544

• Normal sample for patient SA211

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA211

  Dataset EGAD00001009545

• Normal sample for patient SA212

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA212

  Dataset EGAD00001009546

• Normal sample for patient SA214

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA214

  Dataset EGAD00001009547

• Normal sample for patient SA224

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA224

  Dataset EGAD00001009548

• Normal sample for patient SA225

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA225

  Dataset EGAD00001009549

• Normal sample for patient SA226

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA226

  Dataset EGAD00001009550

• Normal sample for patient SA228

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA228

  Dataset EGAD00001009551

• Normal sample for patient SA229

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA229

  Dataset EGAD00001009552

• Normal sample for patient SA230

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA230

  Dataset EGAD00001009553

• Normal sample for patient SA231

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA231

  Dataset EGAD00001009554

• Normal sample for patient SA232

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA232

  Dataset EGAD00001009555

• Normal sample for patient SA233

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA233

  Dataset EGAD00001009556

• Normal sample for patient SA234

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA234

  Dataset EGAD00001009557

• Normal sample for patient SA237

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA237

  Dataset EGAD00001009558

• Normal sample for patient SA271

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA271

  Dataset EGAD00001009559

• Normal sample for patient SA277

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA277

  Dataset EGAD00001009560

• Normal sample for patient SA278

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA278

  Dataset EGAD00001009561

• Normal sample for patient SA095

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA095

  Dataset EGAD00001009600

• Tumour sample for patient SA400

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA400

  Dataset EGAD00001009576

• Tumour sample for patient SA290

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA290

  Dataset EGAD00001009577

• Tumour sample for patient SA288

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA288

  Dataset EGAD00001009578

• Tumour sample for patient SA299

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA299

  Dataset EGAD00001009579

• Tumour sample for patient SA095

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA095

  Dataset EGAD00001009580

• Tumour sample for patient SA415

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA415

  Dataset EGAD00001009581

• Normal sample for patient SA718

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA718

  Dataset EGAD00001009582

• Normal sample for patient SA720

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA720

  Dataset EGAD00001009583

• Tumour sample for patient SA718

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA718

  Dataset EGAD00001009584

• Tumour sample for patient SA720

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA720

  Dataset EGAD00001009585

• Normal sample for patient SA1017

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1017

  Dataset EGAD00001009586

• Normal sample for patient SA1026

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1026

  Dataset EGAD00001009587

• Normal sample for patient SA1027

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1027

  Dataset EGAD00001009588

• Normal sample for patient SA1028

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1028

  Dataset EGAD00001009589

• Normal sample for patient SA1040

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1040

  Dataset EGAD00001009590

• Normal sample for patient SA1064

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1064

  Dataset EGAD00001009591

• Normal sample for patient SA1065

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1065

  Dataset EGAD00001009592

• Normal sample for patient SA1069

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1069

  Dataset EGAD00001009593

• Normal sample for patient SA1073

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1073

  Dataset EGAD00001009594

• Normal sample for patient SA1074

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1074

  Dataset EGAD00001009595

• Normal sample for patient SA576

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA576

  Dataset EGAD00001009596

• Normal sample for patient SA610

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA610

  Dataset EGAD00001009597

• Normal sample for patient SA992

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA992

  Dataset EGAD00001009598

• Normal sample for patient SA994

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA994

  Dataset EGAD00001009599

• Normal sample for patient SA288

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA288

  Dataset EGAD00001009601

• Normal sample for patient SA299

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA299

  Dataset EGAD00001009602

• Normal sample for patient SA415

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA415

  Dataset EGAD00001009603

• Normal sample for patient SA666

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA666

  Dataset EGAD00001009604

• Tumour sample for patient SA1065

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1065

  Dataset EGAD00001009605

• Tumour sample for patient SA1064

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1064

  Dataset EGAD00001009606

• Tumour sample for patient SA1026

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1026

  Dataset EGAD00001009607

• Tumour sample for patient SA1069

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1069

  Dataset EGAD00001009608

• Tumour sample for patient SA1017

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1017

  Dataset EGAD00001009609

• Tumour sample for patient SA1027

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1027

  Dataset EGAD00001009610

• Tumour sample for patient SA1073

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1073

  Dataset EGAD00001009611

• Tumour sample for patient SA1074

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1074

  Dataset EGAD00001009612

• Tumour sample for patient SA576

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA576

  Dataset EGAD00001009613

• Tumour sample for patient SA1028

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1028

  Dataset EGAD00001009614

• Tumour sample for patient SA1040

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1040

  Dataset EGAD00001009615

• Tumour sample for patient SA992

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA992

  Dataset EGAD00001009616

• Tumour sample for patient SA610

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA610

  Dataset EGAD00001009617

• Normal sample for patient SA416

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA416

  Dataset EGAD00001009618

• Normal sample for patient SA1070

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1070

  Dataset EGAD00001009619

• Tumour sample for patient SA1070

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1070

  Dataset EGAD00001009620

• Tumour sample for patient SA997

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA997

  Dataset EGAD00001009621

• Nanopore low-pass WGS of human brain tumors

  Nanopore low-pass WGS of human brain tumors for evaluation of DNA methylation-based classification of cancer

  Dataset EGAD00001009663

• Tumour sample for patient SA1058

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1058

  Dataset EGAD00001009673

• Normal sample for patient SA1058

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1058

  Dataset EGAD00001009672

• Tumour sample for patient SA998

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA998

  Dataset EGAD00001009674

• CCMA

  This dataset has the processed WGS data for the cancer models in CCMA.

  Dataset EGAD00001009633

• TGL49_HBC CHARM panel

  Targeted panel sequencing of hereditary cancer syndrome-associated genes (TP53, BRCA1, BRCA2, PALB2, MLH1, MSH2, MSH6, PMS2, EPCAM, and APC) in plasma and buffy coat samples from healthy control patients.

  Dataset EGAD00001010001

• Sequencing data for the manuscript "Multi-focal sampling of de novo metastatic prostate cancer reveals complex polyclonality and enables accurate clinical genotyping"

  This submission includes targeted and whole exome paired-end fastq files.

  Dataset EGAD00001009651

• Genome and transcriptome sequence data from a rosette-forming glioneuronal tumor (RGNT) tumor patient

  Genome and transcriptome sequence data from a rosette-forming glioneuronal tumor (RGNT) patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015320

• Genome and transcriptome sequence data from a diffuse midline glioma, H3K27 mutant tumor patient

  Genome and transcriptome sequence data from a diffuse midline glioma, H3K27 mutant patient, generated as part of the BC Cancer Agency's Pediatric Personalized Onco-Genomics study

  Dataset EGAD00001015326

• Colorectal organoids and tumour tissue

  Whole genome sequencing of single cell derived organoids from normal colon tissue and colorectal cancer.

  Dataset EGAD00001001447

• The Landscape of Genetic Alterations in Hepatocellular Carcinoma, 88 matched HCC tumour/normal pairs WGS belongs to ICGC LICA-CN project

  Hepatocellular carcinoma (HCC) is the most common malignancy of the liver. Genomic analysis is conducted to identify genetic alterations in driver genes which are all druggable targets for cancer therapy. Whole genome shotgun sequencing (WGS) and the landscaple of somatic mutations in 88 paired samples from HCC patients including tumors and matched adjacent normal tissues using Illumina HiSeq 2000 platform were performed.

  Study EGAS00001002218

• Reproducibility of variant calls in replicate next generation sequencing experiments

  In this study, we examined the reproducibility of nucleotide variant calls in replicate sequencing experiments of the same genomic DNA. We performed targeted sequencing of all known human protein kinase genes (kinome) (~3.3 Mb) using the SOLiD v4 platform. Seventeen breast cancer samples were sequenced in duplicate (n=14) or triplicate (n=3) to assess concordance of all calls and single nucleotide variant (SNV) calls.

  Study EGAS00001000826

• Epigenetic analyses of methylation and nucleosome occupancy in cell-free DNA (cfNOMe)

  Cell-free DNA (cfDNA) has become essential in cancer diagnostics and prenatal testing. We investigate enzymatic cytosine conversion for epigenetic analyses of cfDNA and find that it reliably measures cytosine methylation and nucleosome occupancy. Whereas previously, separate experiments had to be performed to study either epigenetic marking, this approach delivers reliable results for both, enabling more comprehensive and inexpensive epigenetic profiling of cfDNA.

  Study EGAS00001004370

• Prospective high-throughput genome profiling in advanced cancers:

  Genomics-based tumor profiling in advanced cancers (aC) was recently demonstrated as feasible in clinical practice. After the prospective pilot PANDORA study done on advanced breast cancers, we conducted a prospective monocenter clinical trial called PERMED01 to evaluate the number patients with locally advanced or metastatic cancer for whom identification of molecular alterations in tumor samples could lead to the delivery of a targeted therapy

  Study EGAS00001004554